The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...
A new rule posted on the Office of Management and Budget (OMB) registry suggests that the US Drug Enforcement Administration (DEA) is planning an additional extension of COVID-19-era flexibilities for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results